Foundayo vs Wegovy: Which GLP-1 Is Right for You?

Wegovy injectable wins on raw efficacy. In the STEP trials, Wegovy (semaglutide 2.4mg injection) showed approximately 15-17% body weight loss over 68 weeks. That's the gold standard for single-agent GLP-1 weight loss.

Foundayo is competitive but not quite as powerful. In ATTAIN-1, the highest dose (36mg in the trial) showed 12.4% weight loss for completers over 72 weeks. The 12mg dose showed 9.3%, and the 6mg dose showed 7.8%.

Wegovy pill vs Foundayo is closer. Oral semaglutide shows somewhat lower efficacy than injectable Wegovy (the oral bioavailability is only ~1%). When comparing pills to pills, Foundayo and oral Wegovy are in a similar range.

Bottom line: If maximum weight loss is your top priority and you don't mind injections, Wegovy injectable is the stronger drug. If you want a pill, Foundayo and oral Wegovy deliver similar results, but Foundayo wins on convenience (no fasting).

Cost is where Foundayo shines:

• Foundayo self-pay: $149/month (starting dose) to $349/month (highest dose) via LillyDirect
• Wegovy injectable: ~$1,349/month list price
• Wegovy pill: $299/month (high dose) — actually cheaper than Foundayo's highest dose!

With manufacturer savings cards, both can drop to $25/month for commercially insured patients. But for the ~16 million Americans without GLP-1 coverage, the self-pay price is what matters.

Key insight: At lower/middle doses, Foundayo is significantly cheaper. At the highest dose, Wegovy pill ($299) actually undercuts Foundayo ($349). But Foundayo starts at just $149, making it the most affordable way to get started on a GLP-1.

Foundayo wins decisively on convenience:

• Take any time of day — morning, noon, or night
• With or without food and water — no restrictions
• No injection, no needles, no cold storage
• Easy to travel with — no sharps container needed

Wegovy pill requires strict fasting: You must take it on an empty stomach with a small sip of water, then wait 30 minutes before eating, drinking, or taking other medications. For many people, this is a significant daily inconvenience.

Wegovy injection: Once weekly is convenient scheduling-wise, but requires injection, cold storage, and sharps disposal. Some people develop injection fatigue over months or years.

Both medications cause GI side effects — that's the nature of GLP-1s. But the rates differ:

Foundayo (from ATTAIN-1 at highest dose):

• Nausea: ~25%
• Constipation: ~14%
• Diarrhea: ~18%
• Vomiting: ~10%
• Hair loss: ~3%

Wegovy injectable (from STEP trials):

• Nausea: ~44%
• Diarrhea: ~30%
• Vomiting: ~24%
• Constipation: ~24%
• Injection site reactions: ~6%

Foundayo has notably lower GI side effect rates. This may be because orforglipron is a partial agonist (less intense receptor stimulation) compared to semaglutide's full agonism. However, direct comparison is difficult because the trials had different designs and patient populations.

Choose Foundayo if:

• You want a pill with no food/water restrictions
• You're price-sensitive (starting at $149/mo self-pay)
• You've had bad GI side effects on other GLP-1s
• You're starting GLP-1 treatment for the first time
• You're switching from an injectable and want oral convenience

Choose Wegovy if:

• Maximum weight loss is your top priority
• You don't mind weekly injections (for the injectable version)
• You're already on semaglutide and it works for you
• Your insurance covers Wegovy but not Foundayo
• You prefer the longer safety track record (5+ years of data)